Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04588714 · ClinicalTrials.gov registry record · NA
Feasibility and Preliminary Effects of the Resilience-based, Energy Management to Enhance Wellbeing in Systemic Sclerosis (RENEW) Intervention
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT04588714 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 21 participants.
The verdict
NCT04588714, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Researchers are testing a web-based peer-led program to help manage energy and symptoms in people who have scleroderma. Resilience-based, Energy Management to Enhance Wellbeing (RENEW) was created by researchers, doctors, and patients with scleroderma. The goal is to help people with scleroderma feel better.
Interventions
- BEHAVIORAL Resilience-based, Energy Management to Enhance Wellbeing (RENEW)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2020-10-27 |
| Est. Completion | 2021-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04588714
The ClinicalTrials.gov registry entry for NCT04588714 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Resilience-based, Energy Management to Enhance Wellbeing (RENEW) is the first listed.
NCT04588714 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04588714 about?
NCT04588714 is a clinical study titled "Feasibility and Preliminary Effects of the Resilience-based, Energy Management to Enhance Wellbeing in Systemic Sclerosis (RENEW) Intervention". Researchers are testing a web-based peer-led program to help manage energy and symptoms in people who have scleroderma. Resilience-based, Energy Management to Enhance Wellbeing (RENEW) was created by researchers, doctors, and patients with scleroderma. The goal is to help people with scleroderma fee...
What is the current status of trial NCT04588714?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2020-10-27. Estimated completion is 2021-05-31.
What interventions are being tested in trial NCT04588714?
The interventions under investigation include: Resilience-based, Energy Management to Enhance Wellbeing (RENEW) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04588714?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.